Medical Devices Medical Devices

Our sector experience

Baker McKenzie acted as lead counsel for Acorda Therapeutics, formerly a public company listed on NASDAQ, in its USD 185 million sale of substantially all its assets to Merz Therapeutics. The sale was implemented under the protection of Chapter 11 of the U.S. Bankruptcy Code that involved the restructuring of USD 207 million in secured public bond debt pursuant to a Restructuring Support Agreement pursuant to a Chapter 11 Plan and a going-concern section 363 sale of INBRIJA, AMPYRA, and FAMPYRA.

Acorda Therapeutics

CASE STUDY

Baxter USD 3.8 billion

Advised Baxter on the divestiture of Vantive Kidney Care Segment to Carlyle, the deal spanning over 45 jurisdictions.

Abbott USD 890 million

Abbott on its acquisition of Cardiovascular Systems, Inc. in an all-cash transaction valued at approximately USD 890 million.

hearX

Advised hearX in its Merger with Eargo, Creating LXE Hearing. The deal marks the first significant merger in the over-the-counter hearing aid market since the FDA established the regulatory category in 2022.